Nifty

:

11137.30

Sensex

:

37652.00

-113.25 (-1.01%)
-382.14 (-1.00%)

Login

Nifty
Sensex

:
:

11137.30
37652.00

-113.25 (-1.01%)
-382.14 (-1.00%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

59/99

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

631.90

21-Sep-2020

Open
High
Low
Previous Close

655.00
661.00
630.00
654.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

390
69.02
780.00
420.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,560.21
114.05
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

978.30
1.58%
2.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-5.25
-8.67
-8.06

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-22.69
-17.55
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-23.49
-44.89
-49.52

P:E (Median)

8 Years
5 Years
3 Years

28.74
30.57
32.81

P:BV (Average)

8 Years
5 Years
3 Years

1.99
1.99
1.99

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.20
10.56
10.57

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 92.46 109.31 -15.41% 93.70 110.38 -15.11% 117.46 135.62 -13.39% 117.78 106.58 10.51%
Expenses 88.27 114.51 -22.92% 82.69 90.52 -8.65% 108.45 122.12 -11.19% 120.57 124.16 -2.89%
EBITDA 4.19 -5.20 - 11.01 19.86 -44.56% 9.01 13.50 -33.26% -2.79 -17.58 -
EBIDTM 4.53% -4.76% 11.75% 17.99% 7.67% 9.95% -2.37% -16.49%
Other Income 6.96 10.89 -36.09% 7.94 13.43 -40.88% 7.30 11.47 -36.36% 10.01 31.08 -67.79%
Interest 1.68 1.16 44.83% 1.89 0.00 0 1.66 0.03 5,433.33% 1.68 0.03 5,500.00%
Depreciation 3.06 3.22 -4.97% 3.51 0.91 285.71% 3.27 0.95 244.21% 3.14 0.66 375.76%
PBT 6.41 1.31 389.31% 13.55 32.38 -58.15% 11.38 23.99 -52.56% 2.40 12.81 -81.26%
Tax 2.02 0.52 288.46% 6.77 12.85 -47.32% 3.65 11.12 -67.18% 7.62 3.44 121.51%
PAT 4.39 0.79 455.70% 6.78 19.53 -65.28% 7.73 12.87 -39.94% -5.22 9.37 -
PATM 4.75% 0.72% 7.24% 17.69% 6.58% 9.49% -4.43% 8.79%
EPS 1.78 0.32 456.25% 2.74 7.91 -65.36% 3.13 5.21 -39.92% -2.11 3.79 -

Description Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 421.40 438.25 490.68 563.89 656.22 689.77 873.38 862.23 903.36 844.29 751.21 Net Sales Growth -8.77% -10.69% -12.98% -14.07% -4.86% -21.02% 1.29% -4.55% 7.00% 12.39% Cost Of Goods Sold 166.22 182.32 198.65 245.51 306.10 286.31 349.02 386.65 367.39 307.68 270.21 Gross Profit 255.18 255.93 292.03 318.38 350.12 403.46 524.36 475.58 535.97 536.61 481.00 GP Margin 60.56% 58.40% 59.52% 56.46% 53.35% 58.49% 60.04% 55.16% 59.33% 63.56% 64.03% Total Expenditure 399.98 426.51 478.54 572.12 631.70 658.95 881.18 865.65 814.48 702.53 597.36 Power & Fuel Cost - 1.27 1.79 2.56 1.77 4.43 4.87 4.02 3.57 2.64 2.50 % Of Sales - 0.29% 0.36% 0.45% 0.27% 0.64% 0.56% 0.47% 0.40% 0.31% 0.33% Employee Cost - 113.87 117.11 144.53 139.30 156.66 200.03 174.19 162.30 137.68 110.10 % Of Sales - 25.98% 23.87% 25.63% 21.23% 22.71% 22.90% 20.20% 17.97% 16.31% 14.66% Manufacturing Exp. - 39.23 42.21 42.07 49.03 62.35 98.47 104.52 97.61 79.42 68.26 % Of Sales - 8.95% 8.60% 7.46% 7.47% 9.04% 11.27% 12.12% 10.81% 9.41% 9.09% General & Admin Exp. - 23.40 43.28 45.74 45.74 47.65 64.48 62.19 64.16 51.91 38.45 % Of Sales - 5.34% 8.82% 8.11% 6.97% 6.91% 7.38% 7.21% 7.10% 6.15% 5.12% Selling & Distn. Exp. - 53.99 60.29 72.48 75.83 70.74 131.14 101.63 90.68 93.15 82.18 % Of Sales - 12.32% 12.29% 12.85% 11.56% 10.26% 15.02% 11.79% 10.04% 11.03% 10.94% Miscellaneous Exp. - 12.43 15.21 19.23 13.93 30.81 33.17 32.45 28.77 30.05 82.18 % Of Sales - 2.84% 3.10% 3.41% 2.12% 4.47% 3.80% 3.76% 3.18% 3.56% 3.42% EBITDA 21.42 11.74 12.14 -8.23 24.52 30.82 -7.80 -3.42 88.88 141.76 153.85 EBITDA Margin 5.08% 2.68% 2.47% -1.46% 3.74% 4.47% -0.89% -0.40% 9.84% 16.79% 20.48% Other Income 32.21 36.43 78.40 173.81 71.52 244.55 111.58 97.24 84.35 86.14 67.72 Interest 6.91 6.39 1.59 5.53 0.72 0.21 0.21 0.27 0.22 0.54 0.28 Depreciation 12.98 13.14 3.18 2.53 3.59 3.49 4.01 3.65 3.59 2.67 2.38 PBT 33.74 28.64 85.77 157.52 91.73 271.67 99.56 89.90 169.42 224.69 218.91 Tax 20.06 18.56 34.00 79.16 34.51 73.38 14.12 -8.63 49.69 72.67 72.24 Tax Rate 59.45% 64.80% 39.64% 50.25% 37.62% 27.01% 15.15% -9.60% 29.33% 32.34% 33.00% PAT 13.68 10.08 51.77 78.36 57.22 198.29 79.11 98.53 119.73 152.02 146.67 PAT before Minority Interest 13.68 10.08 51.77 78.36 57.22 198.29 79.11 98.53 119.73 152.02 146.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.25% 2.30% 10.55% 13.90% 8.72% 28.75% 9.06% 11.43% 13.25% 18.01% 19.52% PAT Growth -67.86% -80.53% -33.93% 36.95% -71.14% 150.65% -19.71% -17.71% -21.24% 3.65% EPS 5.54 4.08 20.96 31.72 23.17 80.28 32.03 39.89 48.47 61.55 59.38

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 720.73 759.19 733.64 919.64 1,193.58 1,001.99 961.35 900.21 817.87 702.99 Share Capital 12.34 12.34 12.34 14.07 15.98 15.98 15.98 15.98 15.98 15.98 Total Reserves 711.68 751.10 727.48 913.00 1,184.54 986.01 945.37 884.23 801.89 687.01 Non-Current Liabilities 987.42 891.47 897.75 827.53 26.47 696.64 585.68 560.05 498.74 498.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.00 Long Term Provisions 953.97 909.70 916.30 844.46 45.85 714.94 600.01 572.48 511.99 509.99 Current Liabilities 416.93 367.22 481.74 323.21 204.49 361.82 458.91 492.87 477.87 372.66 Trade Payables 72.60 91.40 106.11 73.22 69.66 94.52 107.52 119.59 97.91 79.37 Other Current Liabilities 132.99 51.98 184.52 63.26 88.94 52.24 47.58 40.69 41.12 28.10 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 211.34 223.84 191.11 186.73 45.89 215.06 303.81 332.59 338.84 265.19 Total Liabilities 2,125.08 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94 1,953.13 1,794.48 1,574.00 Net Block 76.28 14.98 4.60 5.71 6.48 8.50 7.87 9.96 10.11 7.97 Gross Block 85.08 23.93 12.09 10.82 9.87 26.08 23.98 25.74 23.53 24.16 Accumulated Depreciation 8.80 8.95 7.49 5.11 3.39 17.58 16.11 15.78 13.42 16.19 Non Current Assets 1,127.81 1,029.20 1,008.86 958.91 160.85 845.95 698.16 638.95 577.00 573.69 Capital Work in Progress 0.00 0.00 0.00 0.01 0.45 0.00 0.00 0.27 0.10 0.16 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.03 0.03 0.03 Long Term Loans & Adv. 1,026.17 990.61 979.98 935.98 153.29 837.20 690.13 628.60 564.37 565.48 Other Non Current Assets 25.36 23.61 24.28 17.21 0.63 0.24 0.13 0.09 2.39 0.05 Current Assets 997.27 988.68 1,104.27 1,111.47 1,263.69 1,214.50 1,307.78 1,314.18 1,217.48 1,000.31 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 58.68 60.51 56.56 87.52 72.40 99.94 103.59 110.15 79.01 53.62 Sundry Debtors 37.60 45.59 43.91 40.83 50.17 82.90 77.40 82.44 69.95 62.81 Cash & Bank 581.91 612.02 775.08 815.72 1,125.55 838.55 16.81 39.30 82.89 88.42 Other Current Assets 319.08 34.54 26.43 20.54 15.57 193.11 1,109.98 1,082.29 985.63 795.46 Short Term Loans & Adv. 259.99 236.02 202.29 146.86 9.99 190.34 1,109.75 1,069.70 976.47 786.37 Net Current Assets 580.34 621.46 622.53 788.26 1,059.20 852.68 848.87 821.31 739.61 627.65 Total Assets 2,125.08 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94 1,953.13 1,794.48 1,574.00

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -23.14 -194.28 160.99 -40.83 56.59 -59.59 -4.56 7.43 74.72 90.55 PBT 28.64 85.77 157.52 91.73 111.37 99.56 89.90 169.42 224.69 218.91 Adjustment -11.80 -72.66 -55.87 -55.95 -67.04 -84.63 -74.44 -70.96 -69.55 -50.13 Changes in Working Capital -1.85 -161.76 117.30 -32.45 91.70 -31.81 10.76 -30.41 5.02 -7.56 Cash after chg. in Working capital 14.99 -148.65 218.95 3.33 136.03 -16.88 26.22 68.05 160.16 161.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -38.13 -45.63 -57.96 -44.16 -79.44 -36.38 -30.78 -60.62 -85.44 -70.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 -6.33 0.00 0.00 0.00 0.00 Cash From Investing Activity 55.91 274.23 68.70 423.64 -630.47 718.94 22.16 -16.06 -42.71 -21.76 Net Fixed Assets -61.15 -11.84 -1.26 -0.51 15.76 -2.10 2.03 -2.38 0.69 -0.21 Net Investments 0.00 0.00 0.00 0.00 0.01 0.02 0.00 0.00 0.00 15.72 Others 117.06 286.07 69.96 424.15 -646.24 721.02 20.13 -13.68 -43.40 -37.27 Cash from Financing Activity -41.41 -29.82 -267.65 -331.80 -38.57 -37.67 -37.79 -37.33 -37.49 -37.51 Net Cash Inflow / Outflow -8.64 50.13 -37.96 51.01 -612.45 621.68 -20.19 -45.96 -5.48 31.28 Opening Cash & Equivalents 87.76 37.63 75.59 24.58 637.03 15.35 35.54 81.50 86.98 57.00 Closing Cash & Equivalent 79.12 87.76 37.63 75.59 24.58 637.03 15.35 35.54 81.50 88.28

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 293.36 309.34 299.76 329.45 375.63 313.51 300.80 281.67 255.90 219.96 ROA 0.49% 2.51% 3.75% 3.27% 11.38% 3.89% 4.98% 6.39% 9.03% 12.53% ROE 1.36% 6.89% 9.40% 5.38% 18.01% 8.06% 10.59% 13.94% 19.99% 22.63% ROCE 4.73% 11.70% 19.72% 8.75% 24.77% 9.52% 9.69% 19.74% 29.61% 33.80% Fixed Asset Turnover 9.77 32.72 59.76 63.43 38.38 34.93 34.80 36.80 35.51 31.68 Receivable days 28.50 27.72 22.59 25.31 35.20 33.46 33.71 30.68 28.61 26.46 Inventory Days 40.83 36.25 38.41 44.47 45.59 42.48 45.08 38.08 28.58 25.46 Payable days 74.34 84.28 68.27 44.09 50.69 46.89 53.76 52.77 50.06 48.90 Cash Conversion Cycle -5.01 -20.31 -7.27 25.70 30.10 29.04 25.04 15.99 7.14 3.02 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 5.48 54.94 29.48 128.40 1294.67 444.95 333.96 771.09 417.09 782.82

Top Investors:

Annual Reports:

News Update:

Novartis - Quarterly Results
6th Aug 2020, 15:45 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback